JP2014506563A5 - - Google Patents

Download PDF

Info

Publication number
JP2014506563A5
JP2014506563A5 JP2013549878A JP2013549878A JP2014506563A5 JP 2014506563 A5 JP2014506563 A5 JP 2014506563A5 JP 2013549878 A JP2013549878 A JP 2013549878A JP 2013549878 A JP2013549878 A JP 2013549878A JP 2014506563 A5 JP2014506563 A5 JP 2014506563A5
Authority
JP
Japan
Prior art keywords
albumin
composition
gene therapy
administered
therapy vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013549878A
Other languages
English (en)
Japanese (ja)
Other versions
JP6010047B2 (ja
JP2014506563A (ja
Filing date
Publication date
Priority claimed from GBGB1101167.3A external-priority patent/GB201101167D0/en
Application filed filed Critical
Publication of JP2014506563A publication Critical patent/JP2014506563A/ja
Publication of JP2014506563A5 publication Critical patent/JP2014506563A5/ja
Application granted granted Critical
Publication of JP6010047B2 publication Critical patent/JP6010047B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013549878A 2011-01-22 2012-01-23 対流強化送達（ｃｅｄ）による選択的複製性単純ヘルペスウイルスベクターの脳への送達 Expired - Fee Related JP6010047B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1101167.3 2011-01-22
GBGB1101167.3A GB201101167D0 (en) 2011-01-22 2011-01-22 Convection enhanced delivery apparatus and method
PCT/GB2012/000062 WO2012098367A1 (en) 2011-01-22 2012-01-23 Delivery of a selectively replicating herpes simplex viral vector to the brain by convection- enhanced delivery (ced)

Publications (3)

Publication Number Publication Date
JP2014506563A JP2014506563A (ja) 2014-03-17
JP2014506563A5 true JP2014506563A5 (OSRAM) 2015-01-29
JP6010047B2 JP6010047B2 (ja) 2016-10-19

Family

ID=43769504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013549878A Expired - Fee Related JP6010047B2 (ja) 2011-01-22 2012-01-23 対流強化送達（ｃｅｄ）による選択的複製性単純ヘルペスウイルスベクターの脳への送達

Country Status (6)

Country Link
US (1) US8901077B2 (OSRAM)
EP (1) EP2665748A1 (OSRAM)
JP (1) JP6010047B2 (OSRAM)
CN (1) CN103328504A (OSRAM)
GB (1) GB201101167D0 (OSRAM)
WO (1) WO2012098367A1 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201204263D0 (en) * 2012-03-12 2012-04-25 Renishaw Plc Giloma treatment
GB201308917D0 (en) * 2013-05-17 2013-07-03 Renishaw Plc Delivery
CN114269936A (zh) * 2019-05-31 2022-04-01 阿维塔斯有限公司 向细胞群的病毒传递方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585096A (en) * 1994-06-23 1996-12-17 Georgetown University Replication-competent herpes simplex virus mediates destruction of neoplastic cells
PT2019683T (pt) * 2006-04-25 2017-03-17 Univ California Administração de fatores de crescimento para o tratamento de distúrbios do snc

Similar Documents

Publication Publication Date Title
Lam et al. Advanced progress of microencapsulation technologies: In vivo and in vitro models for studying oral and transdermal drug deliveries
EP3398616A3 (en) Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
HK1205156A1 (en) Cyclodextrin-based polymers for therapeutic delivery
JP2010280671A5 (OSRAM)
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
EP4353818A3 (en) Compositions, articles of manufacture and methods related to dosing in cell therapy
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
JP2016517888A5 (OSRAM)
BR112013027674A2 (pt) "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
JP2009173664A5 (OSRAM)
EA201492292A1 (ru) Препарат антител
WO2014170389A8 (en) Enhanced adoptive cell therapy
BR112013026363A2 (pt) nanossuspensões de fármaco criodessecadas
BR112014014262A2 (pt) nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
NZ598348A (en) Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
EP2595633A4 (en) METHOD FOR INTRAVENOUS ADMINISTRATION OF GLYBURID AND OTHER MEDICAMENTS
EA201491702A1 (ru) Оптимизированные терапевтические агенты для подкожного введения
JP2012518646A5 (OSRAM)
EP2682101A3 (en) Inhalation Compositions Comprising Glucose Anhydrous
EA201591188A1 (ru) Доставка глатирамера ацетата через слизистую оболочку
EP2925352A4 (en) HONESTICAL INVASIN FOR IMMUNIZATION, DIAGNOSIS AND CELL RELEASE
JP2014506563A5 (OSRAM)
WO2012092305A3 (en) Nanonized iron compositions and methods of use thereof